EGFR compound mutants and survival on erlotinib in non-small cell lung cancer (NSCLC) patients (p) in the EURTAC study Meeting Abstract
| Authors: | Rosell, R.; Molina-Vila, M. A.; Taron, M.; Bertran-Alamillo, J.; Mayo, C.; Vergnenegre, A.; De Marinis, F.; Massuti, B.; De Castro, J.; Gervais, R.; Carcereny, E.; Buges, C.; Moran, T.; Santarpia, M.; Felip, E.; Majem, M.; Bosch, J.; Cardenal, F.; Drozdowskyj, A.; Bivona, T. G. |
| Abstract Title: | EGFR compound mutants and survival on erlotinib in non-small cell lung cancer (NSCLC) patients (p) in the EURTAC study |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009804211 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.7522 |
| Notes: | Meeting Abstract: 7522 -- Source: Wos |
